[18F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase
Marc B. Skaddan(AbbVie (United States)), Sarah R. Mudd(AbbVie (United States)), Kyle C. Wilcox(AbbVie (United States)), Robert A. Comley(AbbVie (United States)), Vaidyanathan Srirajan(National Chemical Laboratory), Kelly D. Foster-Duke(AbbVie (United States)), Ann E. Tovcimak(AbbVie (United States)), Lance Lee(AbbVie (United States)), Aimee Reed(AbbVie (United States)), Sjoerd J. Finnema(Itron (United States)), Dustin Wooten(AbbVie (United States)), Qi Guo(China Medical University), Zhaozhong J. Jia(AbbVie (United States)), Martin J. Voorbach(AbbVie (United States)), Jonathan A. Hickson(AbbVie (United States)), David R. Reuter(AbbVie (United States))
Cited by 4
Related Papers
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
|Annals of Neurology|2020|186
Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor
|Journal of Medicinal Chemistry|2008|140
A quantitation method for mass spectrometry imaging
|Rapid Communications in Mass Spectrometry|2011|92
Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects
|Journal of Nuclear Medicine|2016|77